Hospital medicine prices: what the debate misses about MRP, pharmacies and explanation
The Supreme Court’s questions about medicine prices in private hospitals have been read as a story about hospitals. Look closer and it is mostly a story about how medicine prices are set in India, what a hospital pharmacy actually does, and how little of either is explained to the family at the bedside. Other countries and India’s own government hospitals show the same pressures, handled in different ways. The most useful thing hospitals can do right now is explain.
Key facts at a glance
| What happened | On 30 September 2026 the Supreme Court raised concerns about markups on medicines sold in private hospitals and asked the government to examine the issue, including whether a uniform margin could apply. No order has been passed. The next hearing was reported for 12 October. |
| Reported by | Upstox, 1 October 2026, with earlier coverage on 30 September |
| My take in one line | Patients see a price; almost nobody explains where it comes from. That gap is fixable today, whatever the court decides. |
Who decides the MRP
The maximum retail price printed on a medicine strip is set by the manufacturer, inside rules written by the government. Under the Drugs (Prices Control) Order, 2013, the National Pharmaceutical Pricing Authority fixes ceiling prices for medicines on the national essential medicines list. For everything else, manufacturers set their own price but cannot raise it by more than 10% in a year, as the Centre restated in Parliament in August 2026 (Medical Dialogues). Any seller, whether a neighbourhood chemist, an online pharmacy or a hospital, may sell at or below the MRP, never above it.
So the gap people are shocked by, between what a medicine costs to supply and the MRP on the pack, is created upstream, between the manufacturer and the trade. India already has a tool for it. In 2019 the pricing authority capped trade margins on 42 cancer medicines at 30%; prices of 526 brands came down, some by 90%, with estimated savings of ₹984 crore a year to patients (PIB, 2020). I look at that precedent in what India’s 2019 cancer drug margin cap teaches, and at how MRP works in who actually sets the MRP on your medicine.
What a hospital pharmacy contributes
A hospital pharmacy is not a shop inside a building. It keeps hundreds of medicines in stock around the clock, including emergency drugs that may be used a few times a year and expire on the shelf. It runs a cold chain for vaccines, biologics and many cancer medicines. It prepares chemotherapy doses in controlled conditions to protect patients and staff. It controls which brands enter the hospital, checks for counterfeits and recalls, reconciles medicines at admission and discharge, and works with doctors on interactions and dosing. Accredited hospitals are assessed on all of this.
None of that shows up as a line on the bill. The patient sees an MRP that looks identical to the one at the chemist, sometimes higher than an online discount, and reasonably wonders what they are paying for. What a hospital pharmacy does that a chemist doesn’t goes through it in detail.
How hospitals abroad handle it
Every health system pays for hospital medicines somehow; the difference is whether the patient sees it. In England’s NHS, medicines given to inpatients are free at the point of use and paid for through taxation; outpatient prescriptions carry a flat per-item charge in England and are free in Scotland, Wales and Northern Ireland (House of Commons Library). Many European systems pay hospitals a fixed amount per case, with medicines folded into it, so no medicine line ever reaches the patient.
The United States sits at the other end. Analyses there, including an industry-funded one, have found hospitals are paid well above their acquisition cost for many medicines, and the debate about it has run for years (Pharmacy Times). The pattern is consistent: where medicines are itemised and visible, price becomes a public argument; where they are bundled, it does not.
What happens in India’s government hospitals
Public hospitals tackle cost by making essential medicines free. Under the National Health Mission’s Free Drugs Service Initiative, facilities keep essential medicine lists that range from 106 medicines at a sub health centre to 381 at a district hospital. There are 18,646 Jan Aushadhi Kendras selling generic medicines 50% to 80% cheaper than branded equivalents, 2,370 of them inside government hospitals (PIB, March 2026). AMRIT pharmacies, set up in public hospitals, sell medicines and implants at up to 50% below MRP and report savings of about ₹8,500 crore to patients over ten years (News On AIR).
The trade-off is availability. When stock runs out, patients in public hospitals are often asked to buy medicines outside. Private and public systems are solving different halves of the same problem: one guarantees availability and pays in price, the other controls price and pays in availability.
Why this is a communication problem first
Most families do not object to paying for care. What erodes trust is meeting a price for the first time on a final bill, with no explanation of what it covers. In India the MRP line makes that moment unusually sharp, because the same number is printed on the strip and the patient can look up a discount on their phone in seconds.
- Explain MRP plainly. A short, neutral page on how medicine prices are set in India, and who sets them, answers the question most families now have.
- Show what the pharmacy does. Cold chain, chemotherapy preparation, round-the-clock stock and safety checks are real value that patients never see.
- Put medicines in the estimate. For treatments where medicines are a large share of cost, include them in the written estimate so the final bill holds no surprises. See how to read a hospital estimate.
- Give families someone to ask. A billing or financial counsellor for long stays prevents most disputes before they start.
For patients, how to read an Indian hospital bill and package pricing vs itemised billing explain what each line means. For hospital teams, a communications checklist for when regulation makes headlines covers the next few weeks.
What to watch
The next hearing, whether the court or the government looks upstream at trade margins as in 2019, and whether hospital associations propose common disclosure standards. Clear, consistent explanation now will matter whichever way the policy goes.
Views are my own. This is an explainer on a public issue, not legal, investment or medical advice.
Questions people ask
The manufacturer prints the MRP, within rules set by the government. The National Pharmaceutical Pricing Authority fixes ceiling prices for essential medicines; for other medicines, manufacturers set prices but cannot raise them more than 10% a year.
No. Any seller, including a hospital pharmacy, can sell a medicine at or below its printed MRP, not above it.
Online and retail pharmacies sometimes discount below MRP. Hospital pharmacies usually charge MRP and carry costs that retail does not, such as round-the-clock stock, cold chain and chemotherapy preparation.
Essential medicines are meant to be free in public facilities under the Free Drugs Service Initiative, with lists that vary by facility level. Availability varies, and patients are sometimes asked to buy outside when stock runs out.
In England, NHS inpatient medicines are free at the point of use. Many European systems pay hospitals per case, with medicines included. In the United States, medicines are often itemised and hospital markups are widely debated.
Yes. In 2019 the pricing authority capped trade margins on 42 cancer medicines at 30%, lowering prices of 526 brands, some by about 90%.
Read my takes first in Google Search
